Global Top 16 Companies Accounted for 39% of total End Stage Renal Disease Treatment market | |
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive. The report studies End Stage Renal Disease Treatment market including three main methods of treatment: Hemodialysis, Kidney transplant and Peritoneal dialysis. The global key manufacturers of End Stage Renal Disease Treatment include Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, etc. In 2022, the global top five players had a share approximately 39.0% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com ![]() | |
Target Nation: All Nations Target City : All Cities Last Update : 10 May 2024 3:33 AM Number of Views: 84 | Item Owner : Jessica Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |